Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,737823,Alc12,Alcohol consumption QTL 12,4.5,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),10,17555386,19743866,Rat,n/a,region,qtl 1000,631828,Alc5,Alcohol consumption QTL 5,2.4,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),10,5217199,17555534,Rat,n/a,region,qtl 1000,737820,Alc9,Alcohol consumption QTL 9,2.2,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),10,5217199,19591669,Rat,n/a,region,qtl 1000,1598852,Anxrr19,Anxiety related response QTL 19,5.07,,body movement coordination trait (VT:0005424),number of rearing movements in an experimental apparatus (CMO:0001752),10,19402814,64402814,Rat,n/a,region,qtl 1000,631564,Apr3,Acute phase response QTL 3,3.9,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),10,16468736,61468736,Rat,n/a,region,qtl 1000,1554317,Bmd4,Bone mineral density QTL 4,9.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),10,20170031,102897474,Rat,n/a,region,qtl 1000,2313064,Bmd71,Bone mineral density QTL 71,0.9,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),10,5460119,21524070,Rat,n/a,region,qtl 1000,2313087,Bmd80,Bone mineral density QTL 80,3.2,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),10,19958696,21524070,Rat,n/a,region,qtl 1000,631554,Bp133,Blood pressure QTL 133,,0.005,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,764421,66221621,Rat,n/a,region,qtl 1000,70223,Bp57,Blood pressure QTL 57,5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,21523906,83549467,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,21523906,90312401,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,21523906,90312401,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,21523906,90312401,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),pulse pressure (CMO:0000292),1,21523906,90312401,Rat,n/a,region,qtl 1000,70198,BpQTLcluster9,Blood pressure QTL cluster 9,2.94,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,21523906,90312401,Rat,n/a,region,qtl 1000,2293680,Bss40,Bone structure and strength QTL 40,5.66,0.0001,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),10,1,35538813,Rat,n/a,region,qtl 1000,2313104,Bss61,Bone structure and strength QTL 61,0.9,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),10,5460119,21524070,Rat,n/a,region,qtl 1000,2313095,Bss62,Bone structure and strength QTL 62,1.5,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),10,5460119,21524070,Rat,n/a,region,qtl 1000,2313066,Bss63,Bone structure and strength QTL 63,1.4,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),10,5460119,21524070,Rat,n/a,region,qtl 1000,2313081,Bss64,Bone structure and strength QTL 64,1.3,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),10,5460119,21524070,Rat,n/a,region,qtl 1000,6893352,Bw100,Body weight QTL 100,0.33,0.6,body mass (VT:0001259),body weight (CMO:0000012),1,17121542,62121542,Rat,n/a,region,qtl 1000,2313055,Bw96,Body weight QTL 96,3.6,0.0001,body mass (VT:0001259),body weight (CMO:0000012),10,19958696,21524070,Rat,n/a,region,qtl 1000,6893350,Bw99,Body weight QTL 99,0.87,0.16,body mass (VT:0001259),body weight (CMO:0000012),1,17121542,62121542,Rat,n/a,region,qtl 1000,61427,Cia16,Collagen induced arthritis QTL 16,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,6429075,99492409,Rat,n/a,region,qtl 1000,631268,Cia21,Collagen induced arthritis QTL 21,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,14827894,107857673,Rat,n/a,region,qtl 1000,631532,Cm50,Cardiac mass QTL 50,6.6,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),10,18246394,53637634,Rat,n/a,region,qtl 1000,2301967,Cm73,Cardiac mass QTL 73,4.55,,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),10,14827894,92423564,Rat,n/a,region,qtl 1000,7411611,Foco17,Food consumption QTL 17,18.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),10,1,42669970,Rat,n/a,region,qtl 1000,2316949,Gluco60,Glucose level QTL 60,3.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),10,14827894,110992275,Rat,n/a,region,qtl 1000,634327,Hc4,Hypercalciuria QTL 4,2.4,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),10,1,38594330,Rat,n/a,region,qtl 1000,631660,Hcar1,Hepatocarcinoma resistance QTL 1,3.4,0.0001,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),10,6229289,36185929,Rat,n/a,region,qtl 1000,9589136,Insul27,Insulin level QTL 27,10.46,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),10,12639513,57639513,Rat,n/a,region,qtl 1000,1354587,Kidm21,Kidney mass QTL 21,3.3,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),10,15375474,62469074,Rat,n/a,region,qtl 1000,10401803,Kidm50,Kidney mass QTL 50,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),10,1,44902893,Rat,n/a,region,qtl 1000,2303118,Mamtr7,Mammary tumor resistance QTL 7,,0.003,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,9841807,108540162,Rat,n/a,region,qtl 1000,1549907,Neuinf2,Neuroinflammation QTL 2,27,0,nervous system integrity trait (VT:0010566),MHC Class II RT1A-positive spinal cord ventral horn area to total spinal cord ventral horn area ratio (CMO:0001980),10,6229289,6429075,Rat,n/a,region,qtl 1000,1549898,Neuinf3,Neuroinflammation QTL 3,26.4,,nervous system integrity trait (VT:0010566),MHC Class II RT1A-positive spinal cord ventral horn area to total spinal cord ventral horn area ratio (CMO:0001980),10,2847625,5460218,Rat,n/a,region,qtl 1000,2298544,Neuinf9,Neuroinflammation QTL 9,4.6,,nervous system integrity trait (VT:0010566),"spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)",10,5877536,64401490,Rat,n/a,region,qtl 1000,1576304,Schws7,Schwannoma susceptibility QTL 7,,0.0115,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),10,4835638,20170031,Rat,n/a,region,qtl 1000,9590268,Scort13,Serum corticosterone level QTL 13,3.26,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,12639513,57639513,Rat,n/a,region,qtl 1000,9590310,Scort19,Serum corticosterone level QTL 19,6.3,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,12639513,57639513,Rat,n/a,region,qtl 1000,1578761,Stresp21,Stress response QTL 21,3.3,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),10,7521450,52521450,Rat,n/a,region,qtl 1000,7387235,Uae41,Urinary albumin excretion QTL 41,5.26,0.1874,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),10,1,29592136,Rat,n/a,region,qtl 1000,8662860,Vetf10,Vascular elastic tissue fragility QTL 10,,,artery integrity trait (VT:0010639),number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562),10,6229095,75983805,Rat,n/a,region,qtl